Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NBTX | EMAT |
|---|---|---|
| Price | $25.10 | $2.06 |
| Change today | ▼ 2.52% | ▲ 0.74% |
| Market cap | $1.28B | $1.28B |
| Return, 3 months | -35.3% | -64.4% |
| Return, year to date | +8.6% | – |
| Return, 1 year | +10.2% | – |
| P/E (TTM) | -20.5 | -18.7 |
| P/B | -34.1 | -68.5 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 24 | 31 |
| 30-day volatility | 72.7% | 133.5% |
| Max drawdown, 1 year | -54.4% | -89.3% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
